[acb-diabetics] A1C better at diagnosing...

Mon Mar 22 22:00:06 GMT 2010

Issue 513

A1c Outperforms Fasting Glucose for Diabetes Risk Prediction

Measurements of hemoglobin A1c (HbA1c) more accurately identify persons at
risk for clinical outcomes than the commonly used measurement of fasting
glucose,

according to a new published study.

Advertisement 

HbA1c levels accurately predict future diabetes, and they better predict
stroke, heart disease, and all-cause mortality as well.

Lead author Elizabeth Selvin, PhD, Johns Hopkins Bloomberg School of Public
Health, Baltimore, MD, stated that, as a diagnostic, "Hb A1c has significant

advantages over fasting glucose." The A1c test has low variability from day
to day, levels are not as affected by stress and illness, it has greater
stability,

and the patient is not required to fast before the test is performed.

This study is published on the heels of a major change in the way doctors
diagnose diabetes. In January, the American Diabetes Association (ADA)
published

revised recommendations for the screening and diagnosis of diabetes. The
revised recommendations include, for the first time, recommendations to use
HbA1c

to diagnose diabetes and also to identify people at risk of developing
diabetes in the future.

The new findings can help doctors and patients interpret HbA1c test results.
In the study, people with HbA1c levels between 5.0% to 5.5% were identified

as being within "normal" range. The majority of the U.S. adult population is
within this range. With each incremental HbA1c increase, the study found,

the incidence of diabetes increased as well; those at a level of 6.5% or
greater are considered diabetic, and those between 6.0% and 6.5% are
considered

at a "very high risk" (9 times greater than those at the "normal" range) for
developing diabetes.

The revised ADA guidelines classify people with HbA1c levels in the range of
5.7% to 6.4% as "at very high risk" for developing diabetes over 5 years.
The

range of 5.5% to 6%, according to the ADA guidelines, is the appropriate
level to initiate preventive measures.

The study measured HbA1c in blood samples from more than 11,000 people,
black and white adults, who had no history of diabetes. The samples were
obtained

between 1990 and 1992 as part of the Atherosclerosis Risk in Communities
(ARIC) Study at four ARIC field centres in Hagerstown, MD. The samples have
been

in cold storage since their collection. "It is amazing to be able to use
blood samples collected over a decade ago," said Dr. Selvin, because
researchers

were able to look at participants' measurements and compare to outcomes that
occurred during 15 years of follow-up.

NEJM, March 4, 2010  

Diabetes In Control Advertisers 

http://openx.diabetesincontrol.com/www/delivery/ck.php?oaparams=2__bannerid=
41__zoneid=20__cb=0e2161c91a__oadest=http%3A%2F%2Fwww.a1ctest.com

Flash movie end

Sign up for our FREE Weekly Newsletter 

Current Issue

Past Issue 

images/butnsignup  /

News and Information for Medical Professionals 

Search Diabetes In Control 

throwaway     

list of 10 items

Articles 

list of 5 items nesting level 1

Newsflash 

Diabetes News 

Features 

Feature Writers 

Past Newsletters 

list end nesting level 1

Tools 

list of 3 items nesting level 1

Continuing Education 

Test Your Knowledge     Issue 513

A1c Outperforms Fasting Glucose for Diabetes Risk Prediction

Measurements of hemoglobin A1c (HbA1c) more accurately identify persons at
risk for clinical outcomes than the commonly used measurement of fasting
glucose,